logo
logo
Sign in

Global Autoimmune Disease Diagnostics Market Size & Share Report 2021-2028 | Growth Market Reports

avatar
Sheryl Dias
Global Autoimmune Disease Diagnostics Market Size & Share Report 2021-2028 | Growth Market Reports


 

The global autoimmune disease diagnostics market size is estimated to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing awareness about autoimmune diseases, rising activities of research, educational programs, and growing incidences of autoimmune disease.

 

Request Free Sample Report Here

 

Autoimmune disease refers to a type of the body disorder when the own body immune cells attack the other cells and start to destroying them. This occurs due to the malfunctioning of the immune cells to recognize own body cells, organs, tissues, and producing autoantibodies targeting these cells. Autoimmune diseases mostly comprise of the presence of autoantibodies, self-reactive T cells, and inflammation. Based on the report published by the National Institutes of Health (NIH), the autoimmune disorders is one of the deadliest disease and the mortality rate of the disease is high among women. NIH also reported, 23 million Americans were affected by this disease in 2015 and this number was expected to rise in the near future. As per the Arthritis Foundation, nearly 54 million adults reported in the US suffered with arthritis in the year 2017. Additionally, according to the report of the International Diabetes Federation (IDF), around 420 million adults were suffering from diabetes in 2017, and this number was anticipated to surpass 630 million by 2045, worldwide.

 

Market Trends, Drivers, Restraints, and Opportunities

  • Vast technical improvement in the field of medical science, partnerships with clinical laboratories and physicians, and advanced laboratory automation are key factors propelling the market.
  • Increasing public awareness, high cases of infectious diseases, and rising organizations efforts to cure and diagnose the disease are impacting the market in positive way.
  • Prerequisite of high finance in the installment of diagnosis center and lack of access to the advanced healthcare services in developing regions are key challenges that can hamper the market growth.
  • Lack of skilled professionals in the under-developed and developing countries as well as time consuming diagnosis and large incidence of false results are projected to impede the market growth.

 

Market Segment Insights

 

Systemic autoimmune diagnostics segment is expected to grow at a robust pace

Based on types, the global autoimmune disease diagnostics market is bifurcated into systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics. The systemic autoimmune disease diagnostics is further segmented into ankylosing spondylitis, rheumatoid arthritis, systemic lupus erythematosus, and others. Meanwhile, the localized autoimmune disease diagnostic is further classified into multiple sclerosis, hashimoto's thyroiditis, idiopathic thrombocytopenic purpura, type 1 diabetes, and others.

 

North America is anticipated to constitute a major market share

In terms of regions, the global autoimmune disease diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a major share of the global market during the forecast period owing to the rising implementation of the healthcare policies especially in the US such as Affordable Care Act. The encouraging regulations & initiatives undertaken by the American Autoimmune Related Diseases Association, Inc. (AARDA) made the region a major destination for the market expansion. The aim of this initiative was to reduce the expenses of the disease treatment by diagnosing the disease at an early stage.

 

Compititive Landscape

The key players in global autoimmune disease diagnostics market include F. Hoffmann-La Roche Ltd; Siemens Healthineers; Beckman Coulter, Inc.; EUROIMMUN AG; SQI Diagnostics; Abbott Laboratories; AESKU.Diagnostics GmbH & Co. KG; Quest Diagnostics; Bio-Rad Laboratories, Inc.; Crescendo Bioscience, Inc.; INOVA Diagnostics, Inc.; bioMerieux SA; and Hemagen Diagnostics, Inc.

 

About Growth Market Reports:

GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GROWTH MARKET REPORTS has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.

 

Contact:

Growth Market Reports

Phone: +1 909 414 1393

Email: [email protected]

Web: https://growthmarketreports.com

Follow Us: LinkedIn | Twitter

 


collect
0
avatar
Sheryl Dias
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more